Khalid Usman et al. 2021. EXAMINING DAPAGLIFLOZIN’S IMPACT ON CARDIOVASCULAR HEALTH IN HFREF PATIENTS: DIABETES TYPE 2 CONSIDERATION. Journal of Population Therapeutics and Clinical Pharmacology. 28, 2 (Jul. 2021), 418–422. DOI:https://doi.org/10.53555/jptcp.v28i2.6807.